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A genotype 2 lyssavirus, Lagos bat virus (LBV), was
isolated from a terrestrial wildlife species (water mongoose)
in August 2004 in the Durban area of the KwaZulu-Natal
Province of South Africa. The virus isolate was confirmed
as LBV by antigenic and genetic characterization, and the
mongoose was identified as Atilax paludinosus by mito-
chondrial cytochrome b sequence analysis. Phylogenetic
analysis demonstrated sequence homology with previous
LBV isolates from South African bats. Studies performed in
mice indicated that the peripheral pathogenicity of LBV had
been underestimated in previous studies. Surveillance
strategies for LBV in Africa must be improved to better
understand the epidemiology of this virus and to make
informed decisions on future vaccine strategies because
evidence that current rabies vaccines provide protection
against LBV is insufficient.
L
agos bat virus (LBV) belongs to the genus Lyssavirus
in the family Rhabdoviridae. The prototype lyssavirus
genotype and species, rabies virus (RABV), has a single,
continuous, negative-strand RNA of ≈12,000 nt that codes
for 5 proteins: nucleoprotein, matrix protein, phosphopro-
tein, glycoprotein, and polymerase (1). The Lyssavirus
genus was created after isolation of several viruses in
Africa and Europe that were related to, but serologically
distinct from, RABV (2). 
Seven genotypes (gts) or species in this genus are rec-
ognized (3), and diversity may expand with the addition of
new isolates from Eurasia (4), which are tentative species
in the Lyssavirus genus. RABV (gt1) is distributed world-
wide, Australian bat lyssavirus (gt7) has only been identi-
fied in Australia, and European bat lyssavirus 1 (EBLV-1)
(gt5) and European bat lyssavirus 2 (EBLV-2) (gt6) have
been found only in Europe. Lagos bat virus (LBV) (gt2),
Mokola virus (gt3), and Duvenhage virus (gt4) have been
found only in Africa. 
Recognized lyssavirus genotypes are divided into 2
serologically, pathogenically, and genetically distinct phy-
logroups (5). One phylogroup consists of Mokola virus
and LBV (group II), while all other genotypes are in group
I. Members of phylogroup I are reported to be pathogenic
for mice when introduced intramuscularly and intracere-
brally. In contrast, members of phylogroup II are believed
to be pathogenic in mice only when introduced by the
intracerebral (i.c.) route (5). Commercial vaccine strains
belong to gt1 (RABV) phylogroup 1, and these vaccines
provide protection against RABV and all the other mem-
bers of phylogroup I. However, laboratory data suggest
that these vaccines (gt1 based) will not offer protection
against lyssaviruses in the phylogroup II cluster (6,7). On
the basis of criteria proposed for lyssavirus phylogroups,
West Caucasian bat virus could be considered an inde-
pendent phylogroup III because of genetic distance and
absence of serologic cross-reactivity with phylogroup I
and II viruses (7).
LBV was first isolated from a fruit bat (Eidolon
helvum) in 1956 on Lagos Island in Nigeria (2,8). Fourteen
isolations of this virus have been reported throughout
Africa, including 8 in South Africa (9). Most LBV isolates
were obtained from bats; 2 were from domestic cats
(10,11), and 1 was from a domestic dog in Ethiopia (12).
LBV has never been isolated from any terrestrial wildlife
species.
Globally and throughout Africa, RABV (gt1) is the
most common lyssavirus. In southern Africa, 2 biotypes of
RABV are recognized (13,14): the canid biotype, which
mainly circulates among dogs, jackals, and bat-eared
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Canadafoxes, and the mongoose biotype, which is well adapted
and unique to mongooses in southern Africa (15). RABV
is responsible for all mongoose rabies cases in Africa. In
South Africa, the principal vector of the mongoose biotype
is the yellow mongoose (Cynictis penicillata), but RABV
has been reported in other mongoose species, such as slen-
der (Galerella sanguinea), water (Atilax paludinosus),
small gray (Galerella pulverulenta), banded (Mungos
mungo), selous (Paracynictis selousi), dwarf (Helogale
parvula), and white-tailed (Ichneumia albicauda) mon-
gooses. Mongoose rabies in South Africa commonly
occurs in the central highveld regions (15,16), whereas
KwaZulu-Natal Province, which is located on the east
coast of South Africa, is associated with epizootic canid
rabies in domestic dogs; mongoose rabies is not reported in
this province.
We report the first identification of LBV in a wildlife
terrestrial species, A. paludinosus, commonly known as
the water or marsh mongoose. The mongoose species was
identified by generation and analysis of cytochrome b
sequencing data. We characterized this LBV isolate by
antigenic typing with antinucleocapsid monoclonal anti-
bodies, sequencing of the nucleoprotein gene, and periph-
eral pathogenicity in laboratory mice in comparison with
other LBV isolates from South Africa and a bat RABV iso-
late from North America.
Materials and Methods
Sample Collection
In August 2004, a brain sample from a suspected rabid
mongoose was submitted to the Allerton Veterinary
Institute in Pietermaritzburg, KwaZulu-Natal, South
Africa. The mongoose was captured by the Society for the
Prevention of Cruelty to Animals in a marshy valley in a
residential area in Westville near Durban after the mon-
goose displayed abnormal behavior. The animal was dis-
orientated, attacked inanimate objects, and alternated
between being friendly and aggressive. Only the brain of
the animal was submitted for testing; the carcass was not
preserved. The mongoose species was not identified.
Virus Characterization
Lyssavirus antigen was detected by the standard fluo-
rescent antibody test (FAT) (17), with modifications, by
using a polyclonal fluorescein isothiocyanate–conjugated
immunoglobulin (Rabies Unit, Onderstepoort Veterinary
Institute, Pretoria, South Africa) that could detect all
lyssavirus genotypes. Virus isolation was performed by
using the i.c. mouse inoculation test in suckling mice (18).
Antigenic typing was performed by using the indirect flu-
orescent antibody test with a panel of 16 antinucleocapsid
monoclonal antibodies (N-MAbs) (Centre of Expertise for
Rabies, Canadian Food Inspection Agency, Nepean,
Ontario, Canada) as previously described (19). Genetic
characterization was based on sequencing of the entire
nucleoprotein (N) gene. 
Briefly, total RNA was extracted from infected brain
material with Trizol (Invitrogen, Croningen, the
Netherlands) according to the manufacturer’s instructions.
Complementary DNA was produced by a reverse tran-
scription reaction by using an oligonucleotide primer spe-
cific for the noncoding messenger RNA of the lyssavirus
genome (Lys001: 5′-ACGCTTAACGAMAAA-3′; posi-
tion 1–15 according to the Pasteur virus [PV] RABV
genome, GenBank accession no. M13215). Com-
plementary DNA was amplified with a PCR by using dif-
ferent combinations of the oligonucleotide primers
Lys001, LagNF (9), 550B (5′-GTRCTCCARTTAGCR
CACAT-3′, position 647–666 according to the PV
genome), and 304 (5′-TTGACAAAGATCTTGCTCAT-3′,
position 1514–1533 according to the PV genome) as
described elsewhere (20). The PCR products were visual-
ized after electrophoresis on a 2% agarose gel and purified
by using the Wizard PCR Preps DNA Purification System
(Promega, Madison, WI, USA). The purified products
were sequenced with the BigDye Termination Cycle
Sequencing Ready Reaction Kit 1.1 (Applied Biosystems,
Foster City, CA, USA), according to the manufacturer’s
protocol, with subsequent analysis on an Applied
Biosystems 377 DNA automated sequencer.
Sequence Analysis
DNA sequencing information was compared with
nucleoprotein sequence information for other lyssavirus
genotypes in GenBank, as well as with nucleoprotein
sequencing data obtained during this study from previous
LBV isolates in South Africa from Epomophorus whalber-
gi fruit bats in 1980 (21), 1982 (11), 2003 (9), and 2004
(9), by using the same method as described above.
CLUSTAL W (22) was used to produce sequence align-
ments and generate a neighbor-joining phylogenetic tree.
A graphic representation of the tree was constructed with
the TREEVIEW program (23).
Virus Pathogenicity
Two LBVisolates from South Africa (LBVSA2004) (9)
and the LBV mongoose isolate described in this report
(Mongoose2004), as well as a North American bat RABV
(Myotis spp. variant, isolated in Washington, USA, 2004),
were injected into 4-week-old inbred ICR mice (5
mice/group) by different routes. The i.c. 50% lethal dose
(LD50) was determined by titration of the virus suspension
injected into 4-week-old ICR mice by the i.c. route.
Thereafter, 4-week-old ICR mice were injected with 30 µL
of 103 LD50 of each virus by the i.c. route and 30 µL of 105
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inoculum was prepared by 1 i.c. passage of the original
mongoose brain material in suckling mice.
Species Identification of the LBV-infected Mongoose
Because the mongoose carcass was destroyed, we
attempted to accurately identify the animal by using DNA
sequencing analyses of the mitochondrial cytochrome b
region of mongoose genomic DNAobtained from the brain
sample. The mitochondrial cytochrome b region has been
used to characterize relationships between mongoose
species (24). Genomic DNAwas extracted from mongoose
brain by using the DNeasy Blood and Tissue kit (Qiagen,
Hilden, Germany), followed by PCR conducted according
to the method of Veron et al. (24). PCR products were puri-
fied by using the Wizard SV PCR and gel purification kit
(Promega) and sequenced by using the BigDye
Termination Cycle Sequencing Ready Reaction Kit 3.1
(Applied Biosystems) according to the manufacturer’s pro-
tocol, with subsequent analysis on an Applied Biosystems
3100 DNA automated sequencer. A DNA sequence of 893
bp of the cytochrome b gene was compared with
cytochrome  b sequences for mongooses available in
GenBank by the same method as described earlier for the
analysis of LBV nucleoprotein gene sequences.
Results
Virus Characterization and DNA Sequence Analysis
FAT performed on mongoose brain material showed a
positive reaction for lyssavirus antigen. During the mouse
inoculation test, suckling mice died 9 days after i.c. injec-
tions with mongoose brain suspensions. FAT of the suck-
ling mouse brains showed a positive reaction for lyssavirus
antigen. The isolate reacted with N-MAb 38HF2, which is
an antibody that reacts with all lyssaviruses tested, and
with the antibody N-MAb M612, which is highly specific
for LBV and does not react with any other lyssaviruses
tested. These findings indicate that the new isolate belongs
to LBV (Table).
A reverse transcription–PCR method followed by a
cycle sequencing method was used to amplify and deter-
mine the nucleic acid sequence of the entire nucleoprotein-
encoding gene of the new putative LBV isolate.
Phylogenetic analysis indicated that the new isolate clus-
ters together with LBVisolates from South Africa and with
LBV isolates from Nigeria (2) and Ethiopia (12) (Figure
1). LBV isolates from South Africa, including the new
mongoose isolate of LBV, showed high nucleotide
sequence identity with each other (99.1%–99.7%), com-
pared with low sequence identity (≈82%) with the LBV
isolate from Nigeria. The LBV isolate from Ethiopia (iso-
lated from a dog; GenBank accession no. AY333110)
showed 99.1%–99.9% nucleotide sequence homology
with the South African LBV isolates. This result warrants
further investigation of the DNA sequence identity of the
Ethopian LBV isolate.
Virus Pathogenicity
Genotypes 1 and 2 viruses were pathogenic for mice by
the i.c. and i.m. routes of injection (Figure 2). A similar
death rate was observed for both genotypes (100%) after
i.c. injection of equal amounts of virus (103 LD50 dose).
Although the LBV isolates were lethal to mice when 105
LD50 was injected intramuscularly, they were less efficient
than the RABV isolate. Of mice injected with the LBV
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died after injection with the LBVSA2004 isolate from the
fruit bat E. whalbergi. However, the RABV isolate showed
100% lethality in mice.
Species Identification of the LBV-infected Mongoose
Analysis of 893 bp of the cytochrome b gene obtained
from mongoose brain indicated that the infected animal
shared a 98% DNA nucleotide sequence homology with
the African water mongoose (A. paludinosus) (Figure 3).
Water mongooses are solitary and mainly nocturnal mam-
mals, but they may also be active during the day. These
animals live near water in areas with sufficient bush cover
and have been found throughout sub-Saharan Africa (25).
Discussion
Isolation of LBV from terrestrial wildlife serves as fur-
ther confirmation of our lack of understanding of the inci-
dence and host range of lyssaviruses in Africa. Poor sur-
veillance of rabies-related viruses and poor diagnostic
capability in most of Africa are large contributors to our
lack of information and the obscurity of the African
lyssaviruses. The fluorescent antibody test used as a diag-
nostic test for rabies can only indicate the presence of
lyssavirus antigens and cannot distinguish between
lyssavirus genotypes. To identify a lyssavirus precisely,
antigenic typing or genetic characterization is necessary,
but these techniques are beyond the capability of most lab-
oratories responsible for rabies diagnostics in Africa. Our
phylogenetic analysis indicated a strong nucleoprotein
sequence homology between LBV isolates from South
Africa. Geographic partitioning is a well-known character-
istic of RABV epidemiology worldwide. The strong
sequence homology we observed may result from the
defined geographic location from which all LBV isolates
were obtained.
Although cases in domestic animals have been record-
ed, no human cases of infection with LBV have been doc-
umented. However, cross-neutralization data obtained with
human sera and in rodent models suggest that preexposure
and postexposure treatments for rabies are not effective
against LBV (6,7). The infected mongoose showed aggres-
sive behavior and was captured in a populated residential
area. Although the incidence of the rabies-related viruses
seems to be low, human exposure to these viruses is possi-
ble. Results of pathogenicity experiments indicated that
death can occur from the i.c. and i.m. routes of injection,
although gt2 viruses showed lower lethality to mice when
injected i.m. 
Our results differ from those of another study (5),
which reported that a gt2 virus was not pathogenic to mice
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Figure 1. Neighbor-joining phylogenetic tree comparing nucleotide
sequences of the entire nucleoprotein gene (1,350 nt) of a new
Lagos bat virus (LBV) isolate from a mongoose in South Africa
(Mongoose2004) and representative sequences of all other geno-
types of lyssaviruses. Branch lengths are drawn to scale, and
bootstrap values for 1,000 replicates are shown for the nodes.
Accession numbers for all sequences available from GenBank and
full-length nucleoprotein sequences of other LBV isolates from
South Africa (1980, 1982, 2003, and 2004) are also included.
DUVV, Duvenhage virus; EBLV, European bat lyssavirus; ABLV,
Australian bat lyssavirus; RABV, rabies virus; WCBV, West
Caucasian bat lyssavirus; MOKV, Mokola virus. 
Figure 2. Pathogenicity of genotype 2 (LBVSA2004 [white bars]
and Mongoose2004 [black bars]) and genotype 1 (gray bars)
lyssaviruses in mice. Results are percentages of dead animals
observed for a specific period. Mice were observed for 56 days,
but no deaths occurred after 18 days. A) Deaths after intracerebral
injection of 103 50% lethal doses (LD50). B) Deaths after intramus-
cular injections of 105 LD50.when administered by the i.m. route at the same dose
(3×105 LD50) used in our experiment. What amount of
virus is involved in natural infection is not known.
Cumulatively, our results indicate that LBV may be a
health risk for humans and other mammals, and future vac-
cine strategies against rabies in Africa should consider
these possibilities. Although laboratory data suggest little
cross-neutralization of LBV by rabies preexposure and
postexposure vaccination (7), immune system components
other than neutralizing antibodies may be involved in pro-
tection. Therefore, in the absence of an alternative vaccine,
rabies vaccination and postexposure treatment should still
be advised because of potential cross-reactivity.
This report demonstrated the value of cytochrome b
DNA sequencing for accurately identifying the host in a
rabies case. Diagnostic laboratories do not routinely
receive the complete carcass of suspected rabid animals,
and identification is dependent on reports of persons who
captured the animal or removed its brain before submis-
sion to the diagnostic facility. Host identity is rarely a
problem in domestic animals, but wildlife species show
potential uncertainty, such as demonstrated in the case
reported here. One important aspect of disease epidemiol-
ogy is accurate information about the host species
involved, which enables informed decisions to be made
with regard to the epidemiologic patterns and potential
threats to public and veterinary health.
Identification of the first case of LBV in a mongoose
underscores the need for surveillance of rabies-related
viruses and the need for accurate identification of
lyssavirus genotypes even if the host involved is normally
only associated with RABV. With respect to LBV, we have
recently reported the likely persistence of this virus in
pteropid bats in South Africa, which implicates continuous
opportunity for spillover into terrestrial species (9). In
determining the extent of risk to human and veterinary
public health, it is important to establish the prevalence of
LBV not only in bats but also in potential terrestrial animal
vectors, to which mongoose species should be added,
based on the finding in this report.
The origin of mongoose rabies in South Africa is not
clear (14). Epidemiologic cycles among yellow mongoos-
es and other Herpestidiae are well established and shown
to be impossible to extinguish or control by the attempted
eradication or control of vector and host density (26). With
respect to more modern or scientific approaches, no vacci-
nation strategy has been considered feasible in tackling
this complicated and entrenched wildlife rabies epidemic.
Mongoose rabies may have originated from a spillover
event of a bat lyssavirus progenitor in an event similar to
the spillover described in this report.
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